Drug approval system questioned in US and Canada.
Eggertson
Laura
L
D002170:Canada; D016861:Cyclooxygenase Inhibitors / Q000009:adverse effects; D017277:Drug Approval / Q000331:legislation & jurisprudence*; D006801:Humans; D011358:Product Surveillance, Postmarketing; D018855:Single-Payer System; D014481:United States; D014486:United States Food and Drug Administration
D016861:Cyclooxygenase Inhibitors